HCID 59021684, 화합물 → HCID 11626867, 화합물
반응식
[CH2:1]([O:3][C:4]1[CH:9]=[CH:8][C:7]([S:10]([N:13]([C:29]2[CH:34]=[CH:33][C:32]([CH3:35])=[CH:31][CH:30]=2)[CH2:14][C:15]([NH:17]/[N:18]=[CH:19]/[C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=2[N+:26]([O-])=O)=[O:16])(=[O:12])=[O:11])=[CH:6][CH:5]=1)[CH3:2]>C(Cl)Cl.[Pd]>[NH2:26][C:21]1[CH:22]=[CH:23][CH:24]=[CH:25][C:20]=1/[CH:19]=[N:18]/[NH:17][C:15](=[O:16])[CH2:14][N:13]([C:29]1[CH:30]=[CH:31][C:32]([CH3:35])=[CH:33][CH:34]=1)[S:10]([C:7]1[CH:6]=[CH:5][C:4]([O:3][CH2:1][CH3:2])=[CH:9][CH:8]=1)(=[O:12])=[O:11]참가 물질
4
실험 절차
4-ethoxy-N-(4-methylphenyl)-N-{2-[(2E)-2-(2-nitrobenzylidene)hydrazino]-2-oxoethyl}benzenesulfonamide (99 mg, 0.2 mmol) was dissolved in methylene chloride. Palladium 5% on charcoal was added (10 mol %). The mixture was stirred under H2 at athmospheric pressure at room temperature overnight. It was filtered on Celite and solvents were evaporated. The expected product, e.g. N-{2-[(2E)-2-(2-aminobenzylidene)hydrazino]-2-oxoethyl}-4-ethoxy-N-(4-methylphenyl)benzenesulfonamide (71.2 mg, 76%), was obtained as a light yellow solid, in 90.9% purity by HPLC (MaxPlot detection between 230 and 400 nm).
후처리
- filtrationIt was filtered on Celite and solvents
- customwere evaporated
출처 및 근거
- ORD 기록
- ord-a6cd8e2edeba40da906d6aa8c6cf71c1
- 출처 데이터셋
- uspto-grants-2007_12
- 특허 번호
- US07312358B2
반응 노트
불러오는 중…